Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational basis for optimizing antibiotic dosing regimens.

Francisco Soriano1, Carmen Ponte

  • 1Department of Medical Microbiology, Fundacion Jimenez Diaz, Madrid, Spain.

Folia Medica
|September 15, 2004
PubMed
Summary

Optimizing antibiotic dosage requires correlating pharmacokinetic parameters with bacterial susceptibility, measured by Minimum Inhibitory Concentration (MIC). Different drug classes benefit from specific pharmacodynamic targets for effective antimicrobial treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATA4 loss promotes mutant <i>Kras</i>-driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions.

bioRxiv : the preprint server for biology·2026
Same author

Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma.

Pathology, research and practice·2021
Same author

A microbiological and clinical review on Corynebacterium kroppenstedtii.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2016
Same author

Ether-linked lipids of Dermabacter hominis, a human skin actinobacterium.

Chemistry and physics of lipids·2016
Same author

Molecular Epidemiology of Invasive Listeriosis due to Listeria monocytogenes in a Spanish Hospital over a Nine-Year Study Period, 2006-2014.

BioMed research international·2015
Same author

Draft Genome Sequences of the Two Unrelated Macrolide-Resistant Corynebacterium argentoratense Strains CNM 463/05 and CNM 601/08, Isolated from Patients in the University Hospital of León, Spain.

Genome announcements·2015

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Antibiotic dosage adjustment typically relies on pharmacokinetic parameters.
  • Bacterial response to antibiotics varies, necessitating correlation with antimicrobial susceptibility data.
  • Minimum Inhibitory Concentration (MIC) is a key measure of antimicrobial susceptibility.

Purpose of the Study:

  • To highlight the importance of correlating pharmacokinetic parameters with antimicrobial susceptibility data for optimizing antibiotic dosage.
  • To review various pharmacodynamic parameters and their relationship with antibiotic efficacy across different drug classes.

Main Methods:

  • Review of established pharmacokinetic and pharmacodynamic principles in antibiotic therapy.
  • Analysis of the correlation between different pharmacodynamic indices (e.g., Cmax/MIC, AUC/MIC, T>MIC) and clinical efficacy for various antibiotic classes.

Related Experiment Videos

Main Results:

  • The ratio of maximum antibiotic concentration to MIC (Cmax/MIC) correlates with efficacy for aminoglycosides and fluoroquinolones.
  • The ratio of area under the concentration-time curve to MIC (AUC/MIC) correlates with efficacy for aminoglycosides, fluoroquinolones, vancomycin, tetracyclines, azithromycin, and quinupristin/dalfopristin.
  • The time that antibiotic concentration remains above MIC (T>MIC) correlates with efficacy for beta-lactams, macrolides, and clindamycin.

Conclusions:

  • Pharmacodynamic parameters, including Cmax/MIC, AUC/MIC, and T>MIC, are crucial for optimizing antibiotic dosing strategies.
  • Integrating pharmacokinetic and antimicrobial susceptibility data leads to more effective antibiotic therapy.
  • Consideration of these pharmacodynamic parameters is essential for achieving desired clinical outcomes and combating antimicrobial resistance.